Article
Core structure of S2 from the human coronavirus NL63 spike glycoprotein.
Department of Biochemistry, Weill Medical College of Cornell University, New York, New York 10021, USA.
Biochemistry (impact factor:
3.42).
01/2007;
45(51):15205-15.
DOI:10.1021/bi061686w
pp.15205-15
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence.
[show abstract] [hide abstract]
ABSTRACT: Coronavirus-cell entry programs involve virus-cell membrane fusions mediated by viral spike (S) proteins. Coronavirus S proteins acquire membrane fusion competence by receptor interactions, proteolysis, and acidification in endosomes. This review describes our current understanding of the S proteins, their interactions with and their responses to these entry triggers. We focus on receptors and proteases in prompting entry and highlight the type II transmembrane serine proteases (TTSPs) known to activate several virus fusion proteins. These and other proteases are essential cofactors permitting coronavirus infection, conceivably being in proximity to cell-surface receptors and thus poised to split entering spike proteins into the fragments that refold to mediate membrane fusion. The review concludes by noting how understanding of coronavirus entry informs antiviral therapies.Viruses 04/2012; 4(4):557-80. · 1.50 Impact Factor -
Article: Understanding Human Coronavirus HCoV-NL63.
[show abstract] [hide abstract]
ABSTRACT: Even though coronavirus infection of humans is not normally associated with severe diseases, the identification of the coronavirus responsible for the outbreak of severe acute respiratory syndrome showed that highly pathogenic coronaviruses can enter the human population. Shortly thereafter, in Holland in 2004, another novel human coronavirus (HCoV-NL63) was isolated from a seven-month old infant suffering from respiratory symptoms. This virus has subsequently been identified in various countries, indicating a worldwide distribution. HCoV-NL63 has been shown to infect mainly children and the immunocommpromised, who presented with either mild upper respiratory symptoms (cough, fever and rhinorrhoea) or more serious lower respiratory tract involvement such as bronchiolitis and croup, which was observed mainly in younger children. In fact, HCoV-NL63 is the aetiological agent for up to 10% of all respiratory diseases. This review summarizes recent findings of human coronavirus HCoV-NL63 infections, including isolation and identification, phylogeny and taxonomy, genome structure and transcriptional regulation, transmission and pathogenesis, and detection and diagnosis.The Open Virology Journal 01/2010; 4:76-84.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
14 amino acids
78 degrees C
acute respiratory tract illnesses
causative agent
central triple-stranded coiled coil
denaturant guanidine hydrochloride
extended HR regions
fusion-activating conformational changes
group 1 S glycoproteins
HCoV-NL63 fusion inhibitors
HCoV-NL63 S
HCoV-NL63 S2 fusion core
HCoV-NL63 spike
Human coronavirus NL63
interacting cross-sectional layers
primary target
proteolytic maturation
viral entry
viral entry process
young children